carbamazepine has been researched along with Kidney Diseases in 18 studies
Carbamazepine: A dibenzazepine that acts as a sodium channel blocker. It is used as an anticonvulsant for the treatment of grand mal and psychomotor or focal SEIZURES. It may also be used in the management of BIPOLAR DISORDER, and has analgesic properties.
carbamazepine : A dibenzoazepine that is 5H-dibenzo[b,f]azepine carrying a carbamoyl substituent at the azepine nitrogen, used as an anticonvulsant.
Kidney Diseases: Pathological processes of the KIDNEY or its component tissues.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We report a patient in whom hypersensitivity to carbamazepine presented with generalized erythroderma, a severe leukemoid reaction, eosinophilia, hyponatremia, and renal failure." | 7.67 | Hypersensitivity to carbamazepine presenting with a leukemoid reaction, eosinophilia, erythroderma, and renal failure. ( Boggild, M; Pye, IF; Ray-Chaudhuri, K, 1989) |
| "A man with resistant lithium-induced nephrogenic diabetes insipidus and affective psychosis was successfully treated with carbamazepine." | 7.66 | Treatment of resistant lithium-induced nephrogenic diabetes insipidus and schizoaffective psychosis with carbamazepine. ( Brooks, SC; Lessin, BE, 1983) |
| "We report a patient in whom hypersensitivity to carbamazepine presented with generalized erythroderma, a severe leukemoid reaction, eosinophilia, hyponatremia, and renal failure." | 3.67 | Hypersensitivity to carbamazepine presenting with a leukemoid reaction, eosinophilia, erythroderma, and renal failure. ( Boggild, M; Pye, IF; Ray-Chaudhuri, K, 1989) |
| "A man with resistant lithium-induced nephrogenic diabetes insipidus and affective psychosis was successfully treated with carbamazepine." | 3.66 | Treatment of resistant lithium-induced nephrogenic diabetes insipidus and schizoaffective psychosis with carbamazepine. ( Brooks, SC; Lessin, BE, 1983) |
| "Oxcarbazepine (OCBZ) is a new antiepileptic drug (AED) structurally related to carbamazepine (CBZ) but differing in several important aspects, notably metabolism and induction of metabolic pathways." | 2.39 | Clinical pharmacology and pharmacokinetics of oxcarbazepine. ( Dieterle, W; Flesch, G; Lloyd, P, 1994) |
| "Anticonvulsant therapy was among the first areas to benefit from clinical pharmacokinetic studies." | 2.35 | Clinical pharmacokinetics of anticonvulsants. ( Dam, M; Hvidberg, EF, 1976) |
| " Our data suggest that valproate has adverse effects on renal tubular functions." | 1.42 | Does nephrotoxicity exist in pediatric epileptic patients on valproate or carbamazepine therapy? ( Buyan, N; Demir, E; Gücüyener, K; Gülbahar, Ö; Gürkaş, E; Havali, C; Serdaroğlu, A; Yılmaz, Ü, 2015) |
| " The apparent elimination half-life of the monohydroxy-metabolite [19 (SD 3) h] in these patients was about twice that in healthy subjects." | 1.29 | The effect of renal impairment on the pharmacokinetics of oxcarbazepine and its metabolites. ( Aldigier, JC; Darragon, T; Godbillon, J; Hillion, D; Jungers, P; Kourilsky, O; Lecaillon, JB; Menard, F; Meyer, P; Rouan, MC, 1994) |
| " Experts note that adverse drug reactions (ADRs) have become the 'greatest imitator' of disease in clinical medicine." | 1.28 | Distinguishing drug toxicity syndromes from medical diseases: a QMR computer-based approach. ( Mabry, ME; Miller, RA, 1991) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (44.44) | 18.7374 |
| 1990's | 4 (22.22) | 18.2507 |
| 2000's | 1 (5.56) | 29.6817 |
| 2010's | 4 (22.22) | 24.3611 |
| 2020's | 1 (5.56) | 2.80 |
| Authors | Studies |
|---|---|
| Avdeef, A | 1 |
| Tam, KY | 1 |
| Chen, J | 1 |
| Bai, L | 1 |
| He, Y | 1 |
| Hamed, SA | 1 |
| Rageh, TA | 1 |
| Mohamad, AO | 1 |
| Abou Elnour, SM | 1 |
| Havali, C | 1 |
| Gücüyener, K | 1 |
| Buyan, N | 1 |
| Yılmaz, Ü | 1 |
| Gürkaş, E | 1 |
| Gülbahar, Ö | 1 |
| Demir, E | 1 |
| Serdaroğlu, A | 1 |
| Akar, M | 1 |
| Dilli, D | 1 |
| Yilmaz, Y | 1 |
| Erdeve, O | 1 |
| Oguz, S | 1 |
| Uras, N | 1 |
| Dilmen, U | 1 |
| Brooks, SC | 1 |
| Lessin, BE | 1 |
| Bruni, J | 1 |
| Albright, PS | 1 |
| Asconapé, JJ | 1 |
| Penry, JK | 1 |
| Rouan, MC | 1 |
| Lecaillon, JB | 1 |
| Godbillon, J | 1 |
| Menard, F | 1 |
| Darragon, T | 1 |
| Meyer, P | 1 |
| Kourilsky, O | 1 |
| Hillion, D | 1 |
| Aldigier, JC | 1 |
| Jungers, P | 1 |
| Lloyd, P | 1 |
| Flesch, G | 1 |
| Dieterle, W | 1 |
| Tormey, WP | 1 |
| Verrotti, A | 1 |
| Greco, R | 1 |
| Pascarella, R | 1 |
| Matera, V | 1 |
| Morgese, G | 1 |
| Chiarelli, F | 1 |
| Hvidberg, EF | 1 |
| Dam, M | 1 |
| Hooper, WD | 1 |
| Dubetz, DK | 1 |
| Bochner, F | 1 |
| Cotter, LM | 1 |
| Smith, GA | 1 |
| Eadie, MJ | 1 |
| Tyrer, JH | 1 |
| Mabry, ME | 1 |
| Miller, RA | 1 |
| Ray-Chaudhuri, K | 1 |
| Pye, IF | 1 |
| Boggild, M | 1 |
| De Sousa, RC | 1 |
| Shibasaki, H | 1 |
| Tabira, T | 1 |
| Inoue, N | 1 |
| Goto, I | 1 |
| Kuroiwa, Y | 1 |
5 reviews available for carbamazepine and Kidney Diseases
| Article | Year |
|---|---|
The clinical pharmacology of antiepileptic drugs.
Topics: Adult; Anticonvulsants; Benzodiazepines; Carbamazepine; Drug Interactions; Ethosuximide; Female; Hal | 1984 |
Use of antiepileptic drugs in the presence of liver and kidney diseases: a review.
Topics: Anticonvulsants; Carbamazepine; Epilepsy; Half-Life; Humans; Kidney Diseases; Kinetics; Liver Diseas | 1982 |
Clinical pharmacology and pharmacokinetics of oxcarbazepine.
Topics: Adolescent; Adult; Age Factors; Aged; Anticonvulsants; Antipyrine; Carbamazepine; Child; Cytochrome | 1994 |
Clinical pharmacokinetics of anticonvulsants.
Topics: Administration, Oral; Adult; Aged; Aging; Animals; Anticonvulsants; Carbamazepine; Child; Clonazepam | 1976 |
[Diabetes insipidus--various recent aspects].
Topics: Animals; Arginine; Carbamazepine; Chlorpropamide; Clofibrate; Cyclic AMP; Diabetes Insipidus; Hypoth | 1974 |
1 trial available for carbamazepine and Kidney Diseases
| Article | Year |
|---|---|
Carbamazepine for painful crises in Fabry's disease.
Topics: Adult; Carbamazepine; Clinical Trials as Topic; Evaluation Studies as Topic; Glycolipids; Humans; Ki | 1973 |
12 other studies available for carbamazepine and Kidney Diseases
| Article | Year |
|---|---|
How well can the Caco-2/Madin-Darby canine kidney models predict effective human jejunal permeability?
Topics: Animals; Disease Models, Animal; Dogs; Humans; Jejunal Diseases; Kidney Diseases; Models, Biological | 2010 |
A possible case of carbamazepine-induced renal phospholipidosis mimicking Fabry disease.
Topics: alpha-Galactosidase; Carbamazepine; Fabry Disease; Humans; Kidney; Kidney Diseases; Male; Proteinuri | 2022 |
Renal dysfunctions/injury in adult epilepsy patients treated with carbamazepine or valproate.
Topics: Adolescent; Adult; Anticonvulsants; Carbamazepine; Creatinine; Cross-Sectional Studies; Epilepsy; Fe | 2018 |
Does nephrotoxicity exist in pediatric epileptic patients on valproate or carbamazepine therapy?
Topics: Adolescent; Anticonvulsants; Carbamazepine; Case-Control Studies; Child; Creatinine; Cystatin C; Epi | 2015 |
A case of fetal carbamazepine syndrome with right hemihypoplasia of the entire body.
Topics: Abnormalities, Drug-Induced; Anticonvulsants; Bone and Bones; Carbamazepine; Congenital Abnormalitie | 2012 |
Treatment of resistant lithium-induced nephrogenic diabetes insipidus and schizoaffective psychosis with carbamazepine.
Topics: Adult; Carbamazepine; Diabetes Insipidus; Humans; Kidney Diseases; Lithium; Lithium Carbonate; Male; | 1983 |
The effect of renal impairment on the pharmacokinetics of oxcarbazepine and its metabolites.
Topics: Adult; Aged; Anticonvulsants; Carbamazepine; Female; Humans; Kidney Diseases; Male; Middle Aged; Oxc | 1994 |
Mechanisms of carbamazepine-induced antidiuresis.
Topics: Arginine Vasopressin; Carbamazepine; Female; Humans; Hypernatremia; Kidney Diseases; Male; Osmolar C | 1993 |
Renal tubular function in patients receiving anticonvulsant therapy: a long-term study.
Topics: Adolescent; Age Factors; Anticonvulsants; Carbamazepine; Child; Epilepsy; Female; Follow-Up Studies; | 2000 |
Plasma protein binding of carbamazepine.
Topics: Adolescent; Adult; Aged; Blood Proteins; Carbamazepine; Erythrocytes; Female; Humans; Kidney Disease | 1975 |
Distinguishing drug toxicity syndromes from medical diseases: a QMR computer-based approach.
Topics: Aged; Artificial Intelligence; Brain Diseases; Carbamazepine; Decision Support Techniques; Diagnosis | 1991 |
Hypersensitivity to carbamazepine presenting with a leukemoid reaction, eosinophilia, erythroderma, and renal failure.
Topics: Adult; Carbamazepine; Dermatitis, Exfoliative; Drug Hypersensitivity; Eosinophilia; Female; Humans; | 1989 |